Cash on Hand for Incyte (INCY)
According to Incyte's latest reported financial statements, the company's latest reported cash and short-term investments is $4.02B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
INCY
Currently viewingCash on HandSwitch metric
Latest period
$4.02B
YoY change
+65.9%
5Y CAGR
+14.7%
Peak year (2023)
$3.66B
Latest annual
$3.58B
Cash on Hand history chart for Incyte (INCY) from 1993 to 2025
Cash on Hand history table for Incyte (INCY) from 1993 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $3.58B | +65.9% | ||
| 2024 | $2.16B | -41.0% | ||
| 2023 | $3.66B | +12.9% | ||
| 2022 | $3.24B | +37.9% | ||
| 2021 | $2.35B | +30.4% | ||
| 2020 | $1.80B | -14.9% | ||
| 2019 | $2.12B | +47.2% | ||
| 2018 | $1.44B | +23.0% | ||
| 2017 | $1.17B | +44.7% | ||
| 2016 | $808.55M | +14.2% | ||
| 2015 | $707.78M | +17.9% | ||
| 2014 | $600.26M | +17.9% | ||
| 2013 | $509.00M | +122.8% | ||
| 2012 | $228.42M | -17.7% | ||
| 2011 | $277.59M | -34.6% | ||
| 2010 | $424.17M | -9.8% | ||
| 2009 | $470.42M | +137.6% | ||
| 2008 | $198.02M | -22.8% | ||
| 2007 | $256.43M | -19.5% | ||
| 2006 | $318.57M | -7.7% | ||
| 2005 | $344.97M | -26.6% | ||
| 2004 | $469.76M | +59.9% | ||
| 2003 | $293.81M | -31.5% | ||
| 2002 | $429.02M | -15.5% | ||
| 2001 | $507.90M | -12.8% | ||
| 2000 | $582.18M | +770.2% | ||
| 1999 | $66.90M | +33.8% | ||
| 1998 | $50.00M | -2.3% | ||
| 1997 | $51.20M | +573.7% | ||
| 1996 | $7.60M | -26.9% | ||
| 1995 | $10.40M | +52.9% | ||
| 1994 | $6.80M | -56.1% | ||
| 1993 | $15.50M | — |
Cash on Hand values are taken from Incyte's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Incyte (INCY) reported cash and short-term investments of $3.58B – surged 65.9% year-over-year.
Over 2020–2025 (5 years), Incyte cash and short-term investments expanded at a +14.7% compound annual rate, with the latest reading among the more recent periods of the dataset.
Incyte cash and short-term investments peaked at $3.66B in 2023; the latest annual figure is $3.58B in 2025 (2.1% below peak).
2023 marks the peak cash and short-term investments at $3.66B, with the historical low of $6.80M recorded in 1994.
Among 8 Healthcare peers, Incyte (INCY) ranks 9th; the peer median for cash and short-term investments is $11.85B.
Incyte Cash on Hand by Year
Incyte Cash on Hand 2025: $3.58B
Incyte cash and short-term investments in 2025 was $3.58B, surged 65.9% from 2024.
Incyte Cash on Hand 2024: $2.16B
Incyte cash and short-term investments in 2024 was $2.16B, plunged 41.0% below 2023.
Incyte Cash on Hand 2023: $3.66B
Incyte cash and short-term investments in 2023 was $3.66B, grew 12.9% from 2022. This figure represents the highest annual value in the available history.
Incyte Cash on Hand 2022: $3.24B
Incyte cash and short-term investments in 2022 was $3.24B, surged 37.9% from 2021.
Incyte Cash on Hand 2021: $2.35B
Incyte cash and short-term investments in 2021 was $2.35B.
See more financial history for Incyte (INCY).
Sector peers — Cash on Hand
Companies in the same sector as Incyte, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Incyte's cash and short-term investments?
- Latest reported cash and short-term investments for Incyte (INCY) is $4.02B (period ending March 31, 2026).
How has Incyte cash and short-term investments changed year-over-year?
- Incyte (INCY) cash and short-term investments changed +65.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Incyte cash and short-term investments?
- Incyte (INCY) cash and short-term investments compound annual growth rate is +14.7% over the most recent 5 years available.
When did Incyte cash and short-term investments hit its highest annual value?
- Incyte cash and short-term investments reached its highest annual value of $3.66B in 2023.
What was Incyte cash and short-term investments in 2024?
- Incyte (INCY) cash and short-term investments in 2024 was $2.16B.
What was Incyte cash and short-term investments in 2025?
- Incyte (INCY) cash and short-term investments in 2025 was $3.58B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INCY Overview
Company profile, financial tools, and key metrics
INCY Revenue Counter
Earns $163.03 every second. See per minute, hour, and day.
INCY Earnings Counter
Earns $40.80 per second net profit. See per minute, hour, and day.
INCY Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
INCY What If Invested
What if you had invested $1,000? See historical returns from any date.
INCY How It Makes Money
Discover visual breakdown of $5.14B in revenue — where it comes from and where it goes.
INCY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INCY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INCY Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
INCY Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
INCY Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.